Profile and potential of ixabepilone in the treatment of pancreatic cancer

por Smaglo, Brandon G, Pishvaian, Michael J
Publicado 2014

Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcioma: a single center experience

por Kim, Alexander Y., Unger, Keith, Wang, Hongkun, Pishvaian, Michael J.
Publicado 2016

BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer

por Pishvaian, Michael J, Biankin, Andrew V, Bailey, Peter, Chang, David K, Laheru, Daniel, Wolfgang, Christopher L, Brody, Jonathan R
Publicado 2017

A Phase I Study of Ribociclib Plus Everolimus in Patients with Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy

por Weinberg, Benjamin A., Wang, Hongkun, Witkiewicz, Agnieszka K., Marshall, John L., He, Aiwu R., Vail, Paris, Knudsen, Erik S., Pishvaian, Michael J.
Publicado 2020

Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma

por Gabrielson, Andrew, Tesfaye, Anteneh A., Marshall, John L., Pishvaian, Michael J., Smaglo, Brandon, Jha, Reena, Dorsch-Vogel, Karen, Wang, Hongkun, He, Aiwu Ruth
Publicado 2015

Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment

por Rao, Shruti, Beckman, Robert A., Riazi, Shahla, Yabar, Cinthya S., Boca, Simina M., Marshall, John L., Pishvaian, Michael J., Brody, Jonathan R., Madhavan, Subha
Publicado 2016

Genetic Drivers of Pancreatic Cancer Are Identical Between the Primary Tumor and a Secondary Lesion in a Long-Term (>5 Years) Survivor After a Whipple Procedure

por Bauer, Tyler M., Dhir, Teena, Strickland, Adam, Thomsett, Henry, Goetz, Austin B., Cannaday, Shawnna, Brody, Jonathan R., Pishvaian, Michael J., Yeo, Charles J.
Publicado 2018

WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner

por Lal, Shruti, Zarei, Mahsa, Chand, Saswati N., Dylgjeri, Emanuela, Mambelli-Lisboa, Nicole C., Pishvaian, Michael J., Yeo, Charles J., Winter, Jordan M., Brody, Jonathan R.
Publicado 2016

Pharmacogenomic characterization of gemcitabine response – a framework for data integration to enable personalized medicine

por Harris, Michael, Bhuvaneshwar, Krithika, Natarajan, Thanemozhi, Sheahan, Laura, Wang, Difei, Tadesse, Mahlet G., Shoulson, Ira, Filice, Ross, Steadman, Kenneth, Pishvaian, Michael J., Madhavan, Subha, Deeken, John
Publicado 2014

Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations

por Gong, Jun, Blais, Edik M., Bender, Joseph R., Guan, Michelle, Placencio-Hickok, Veronica, Petricoin, Emanuel F., Pishvaian, Michael J., Gregory, Gary, Tuli, Richard, Hendifar, Andrew E.
Publicado 2019

A Pilot Trial of Molecularly Tailored Therapy for Patients with Metastatic Pancreatic Ductal Adenocarcinoma

por Tesfaye, Anteneh A., Wang, Hongkun, Hartley, Marion L., He, Aiwu Ruth, Weiner, Louis, Gabelia, Nina, Kapanadze, Lana, Shezad, Muhammad, Brody, Jonathan R., Marshall, John L., Pishvaian, Michael J.
Publicado 2019

A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies

por Trivedi, Neel D., Armstrong, Samantha, Wang, Hongkun, Hartley, Marion, Deeken, John, Ruth He, A., Subramaniam, Deepa, Melville, Heather, Albanese, Chris, Marshall, John L., Hwang, Jimmy, Pishvaian, Michael J.
Publicado 2021

Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic cancer

por TIAN, XUEFEI, SHIVAPURKAR, NARAYAN, WU, ZHENG, HWANG, JIMMY J., PISHVAIAN, MICHAEL J., WEINER, LOUIS M., LEY, LISA, ZHOU, DAN, ZHI, XIULING, WELLSTEIN, ANTON, MARSHALL, JOHN L., HE, AIWU RUTH
Publicado 2016

Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma

por Gurka, Marie K., Kim, Christine, He, Aiwu Ruth, Charabaty, Aline, Haddad, Nadim, Turocy, Jenna, Johnson, Lynt, Jackson, Patrick, Weiner, Louis M., Marshall, John L., Collins, Sean P., Pishvaian, Michael J., Unger, Keith
Publicado 2017

A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors

por Cohen, Ezra E. W., Pishvaian, Michael J., Shepard, Dale R., Wang, Ding, Weiss, Jared, Johnson, Melissa L., Chung, Christine H., Chen, Ying, Huang, Bo, Davis, Craig B., Toffalorio, Francesca, Thall, Aron, Powell, Steven F.
Publicado 2019

Retrospective Case Series Analysis of RAF Family Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies

por Hendifar, Andrew, Blais, Edik M., Wolpin, Brian, Subbiah, Vivek, Collisson, Eric, Singh, Isha, Cannon, Timothy, Shaw, Kenna, Petricoin, Emanuel F., Klempner, Samuel, Lyons, Emily, Wang-Gillam, Andrea, Pishvaian, Michael J., O'Reilly, Eileen M.
Publicado 2021

Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety

por Gurka, Marie K, Collins, Sean P, Slack, Rebecca, Tse, Gary, Charabaty, Aline, Ley, Lisa, Berzcel, Liam, Lei, Siyuan, Suy, Simeng, Haddad, Nadim, Jha, Reena, Johnson, Colin D, Jackson, Patrick, Marshall, John L, Pishvaian, Michael J
Publicado 2013

A Novel HRD Signature Is Predictive of FOLFIRINOX Benefit in Metastatic Pancreatic Cancer

por Chen, Kuei-Ting, Madison, Russell, Moore, Jay, Jin, Dexter, Fleischmann, Zoe, Newberg, Justin, Schrock, Alexa, Bhardwaj, Neeru, Lofgren, Katherine T, He, Jie, Frampton, Garrett, Hegde, Priti, Fabrizio, David, Pishvaian, Michael J, Ebot, Ericka, Singhi, Aatur, Sokol, Ethan
Publicado 2023

A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) in...

por Pishvaian, Michael J., Joseph Bender, R., Matrisian, Lynn M., Rahib, Lola, Hendifar, Andrew, Hoos, William A., Mikhail, Sam, Chung, Vincent, Picozzi, Vincent, Heartwell, Craig, Mason, Kimberly, Varieur, Katelyn, Aberra, Metasebia, Madhavan, Subha, Petricoin, Emanuel, Brody, Jonathan R.
Publicado 2016

Human Pancreatic Cancer-Associated Stellate Cells Remain Activated after in vivo Chemoradiation

por Cabrera, M. Carla, Tilahun, Estifanos, Nakles, Rebecca, Diaz-Cruz, Edgar S., Charabaty, Aline, Suy, Simeng, Jackson, Patrick, Ley, Lisa, Slack, Rebecca, Jha, Reena, Collins, Sean P., Haddad, Nadim, Kallakury, Bhaskar V. S., Schroeder, Timm, Pishvaian, Michael J., Furth, Priscilla A.
Publicado 2014